Pre-natal blood test study leads to 'unexpected' cancer diagnosis in three women

June 5, 2015, Cancer Research UK
Pre-natal blood test study leads to ‘unexpected’ cancer diagnosis in three women

Researchers in Belgium trying to improve a blood test used to spot foetal disorders have found unexpected signs of cancer in three of the 4000 pregnant women on their study.

UK experts said the findings were 'important', but stressed that there was a long way to go before the work could be harnessed to routinely improve cancer diagnosis or treatment.

Non-invasive pre-natal testing, or NIPT, is used to test for conditions such as Down's syndrome before birth. It works by looking for certain changes in a foetus's DNA that can be isolated from the mother's blood.

It is not generally used on the NHS but is available privately.

Dr Nathalie Brison, from the Centre for Human Genetics in Leuven, Belgium, said her team initially set out to improve the accuracy of the test.

"Even though [NIPT] is very reliable, we believed that we could make it even better," she said.

A key challenge was to try to test for a wider range of genetic abnormalities.

Using their experimental test in more than 4000 women, the team identified abnormalities in three of them that could not be linked to either the mother or her foetus.

Further analysis revealed DNA changes that "bore a resemblance to those found in cancer, and [we] referred the women to the oncology unit," said Brison.

After whole body MRI scanning and subsequent tissue analysis, the three women were diagnosed with ovarian cancer, a follicular lymphoma, and a Hodgkin lymphoma.

Two out of the three women were treated, one of them during pregnancy. She subsequently gave birth to a healthy girl.

Follow-up investigations in the treated women showed that their DNA profiles became normal again during and after chemotherapy. This, the researchers say, suggests that the technique had the added advantage of monitoring how effective the treatment is.

The third woman had an 'indolent' (slow growing) lymphoma that did not immediately need treatment.

Professor Jacqui Shaw, a Cancer Research UK expert in tumour DNA analysis, said: "These important findings highlight the growing evidence that a cancer's abnormal DNA may be present in a person's blood, and that this could be used to help diagnose, track and the disease. This includes detecting an undiagnosed cancer during pregnancy, allowing for treatment during pregnancy.

"But larger studies will be needed to confirm these 'proof of concept' findings, and ensure this type of analysis is accurate before it could be tested in clinical trials."

The findings have already led to further research, including a study monitoring the blood of people with Hodgkin lymphoma after treatment.

The study was published in the journal JAMA Oncology.

Explore further: Invasive procedures down with noninvasive prenatal testing

More information: "Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing" JAMA Oncol. Published online June 05, 2015. doi:10.1001/jamaoncol.2015.1883

"Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study." DOI: dx.doi.org/10.1016/S2352-3026(14)00039-8

Related Stories

Invasive procedures down with noninvasive prenatal testing

December 18, 2014
(HealthDay)—The number of invasive diagnostic procedures, including amniocentesis, is down significantly after the introduction of noninvasive prenatal testing (NIPT), according to a study published in the January issue ...

Study finds NIPT detects more than 80 percent of chromosomal abnormalities

February 3, 2014
In a study to be presented on Feb. 6 at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in New Orleans, researchers will report that noninvasive prenatal testing detected 83.2 percent of chromosomal ...

ASHG and ESHG issue position statement on non-invasive prenatal screening

March 25, 2015
Two of the world's largest professional societies of human geneticists have issued a joint position statement on the promise and challenges of non-invasive prenatal testing (NIPT), a new procedure to test blood drawn from ...

Study confirms accuracy of its NIFTY in nearly 147,000 pregnancies

February 5, 2015
BGI has published a study tracking the clinical performance of its whole genome sequencing-based non-invasive prenatal test (the NIFTY test) in nearly 147,000 pregnancies, the largest such study to date. The results showed ...

Abnormalities in pregnancies with failures for noninvasive prenatal testing

February 2, 2015
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report on the high rate ...

Changes to prenatal screening for Down syndrome suggested

December 5, 2013
Western Australian researchers say the inclusion of non-invasive prenatal testing (NIPT) into the current Down syndrome screening program would increase detection rates, reduce invasive diagnostic testing and as a result ...

Recommended for you

Artificial placenta created in the laboratory

August 14, 2018
In order to better understand important biological membranes, it is necessary to explore new methods. Researchers at Vienna University of Technology (Vienna) have succeeded in creating an artificial placental barrier on a ...

The inequalities of prenatal stress

August 14, 2018
Exposure to an acute stress in utero can have long-term consequences extending into childhood – but only among children in poor households, according to a new Stanford study that looked at the long-term impact of acute, ...

Better studies needed on effectiveness of fertility awareness-based methods for contraception

August 10, 2018
A new systematic review provides the most comprehensive assessment to date on the scientific evidence estimating the effectiveness of various fertility awareness-based methods (FABMs) for contraception. "Effectiveness of ...

Inducing labor at 39 weeks reduces likelihood of C-sections

August 8, 2018
Inducing labor in healthy first-time mothers in the 39th week of pregnancy results in lower rates of cesarean sections compared with waiting for labor to begin naturally at full term, according to a multicenter study funded ...

Three-dimensional model of human placenta developed

August 3, 2018
The placenta is the organ connecting mother and embryo. Its main functions are the exchange of nutrients, gases and metabolic products and the production of hormones and other substances essential for embryonic development. ...

Pregnant women encouraged to eat cold-water fish

August 3, 2018
Pregnant women who had low plasma levels of long-chain n-3 fatty acids in their first and second trimesters were at a significantly higher risk of early preterm birth when compared with women who had higher levels of these ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.